Hyperion Therapeutics Announces First Patient Enrolled In Trial In Children With Urea Cycle Disorders
Links shared publicly online about this topic.
- 1,742total visits
Hyperion Therapeutics Announces First Patient Enrolled In Trial In Children With Urea Cycle Disorders
Hyperion Therapeutics announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle dis
View full resource at medicalnewstoday.com
Tags: Disease and Condition, Clinical Trial, Children's Health
Most Recently Shared on September 17, 2009 at 2:07 pm By:
Hyperion Therapeutics Announces First Patient Enrolled In Trial In Children With Urea Cycle Disorders: Hyperion .. http://bit.ly/3ro3xO
Hyperion Therapeutics Announces First Patient Enrolled In Pivotal Trial In Patients With Urea Cycle Disorders
medicalnewstoday.com — “Hyperion Therapeutics announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-ce” View full resource at medicalnewstoday.com
Most Recently Shared on October 29, 2009 at 10:33 am By:
MNT Pediatrics News Pediatrics and Health News
Hyperion Therapeutics Announces First Patient Enrolled In Pivotal Trial In Patients With Urea Cycle Disorders: .. http://bit.ly/1vntlq
Advertisement
